Why Merrill Lynch Now Favors Large Cap Leaders in Biotech
These four top large cap biotechs are very good bets for investors looking to add high-quality companies with less volatility and binary clinical data risk.
These four top large cap biotechs are very good bets for investors looking to add high-quality companies with less volatility and binary clinical data risk.
A new research report from Jefferies spotlights new growth stock calls for clients this week, and we highlight three that look very promising right now.
These are the kind of quality stocks investors can put into a portfolio and, for the most part, forget about.
These Deutsche Bank stocks to Buy are for aggressive accounts that have a high tolerance for risk. With that caveat in mind, the upside potential is worth the shot.
A new report from Cowen points out that many skittish portfolio managers are anxiously awaiting third-quarter numbers to make sure that the biotech thesis is still in place.
While the Deutsche Bank team really doesn't go out on a limb with the firm's top Internet stock calls, they are one of a very few on Wall Street in the bullish camp for…
Credit Suisse is adding some top conservative dividend-paying stocks to its Top Picks list, and that is right in line with what other top Wall Street firms are doing.
Insider buying continues to swamp insider selling, and ever since the markets started to sell off hard in late August that has been the case.
Wikimedia CommonsIf there was ever a time when investors are thrilled to see the calendar change it could be now. With the fourth quarter just starting, many are more than relieved to put the…
After the worst quarter in the stock market in four years, a new research report from Merrill Lynch includes the firm's top 10 U.S. ideas for the fourth quarter.
While energy is still a contrarian trade, the way to play it is with the big integrated stocks and exploration and production companies that pay a solid dividend.
The third quarter finally came to an end, and investors were glad to see it put in the record books.
New innovations often can generate revenues through an ecosystem in technology as the applications are spread over many subsectors.
According to a new research report from Merrill Lynch, depending on the final tally, September was possibly the worst month in history for the energy MLPs.
A recent research report from Jefferies highlights the firm's top new value stock picks, which may be just the ticket for nervous investors.
A new report from Deutsche Bank makes the case that the selling in health care stocks is way overdone, and the proverbial baby is being tossed out with the bath water.
The market volatility has left all investors a touch shaken, but the chatter of a bear market and a collapse ring pretty hollow when the economy is not in recession.
The recent sell-off is the largest in some time and offers growth and income investors an incredible opportunity to buy high-yielding blue chips at bargain prices.
Jefferies is basically positive overall going into earnings, and many on Wall Street are projecting a solid fourth-quarter run for the markets.
In a recent Cowen research report, well-respected airlines analyst Helane Becker and her team continue to believe valuations for the airlines remain very compelling.